Cincinnati, OH, United States of America

Jarek Meller


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jarek Meller: Innovator in Immune Response Modulation

Introduction

Jarek Meller is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of immunology, particularly in the development of compounds that modulate immune responses. With a total of 4 patents, Meller's work is focused on addressing inflammation-related diseases.

Latest Patents

Meller's latest patents include innovative compounds useful for inhibiting BFL1 and their application in therapy. The first patent discloses compounds of Formula I and their use in methods of modulating an immune response by inhibiting BFL1. This work is particularly relevant for treating and preventing diseases characterized by inflammation, especially those induced by neutrophils. Another patent outlines methods of attenuating an immune response through the inhibition of BFL1, further emphasizing the potential for therapeutic applications in inflammatory disorders.

Career Highlights

Throughout his career, Jarek Meller has worked with esteemed institutions such as Children's Hospital Medical Center and the University of Cincinnati. His research has significantly advanced the understanding of immune modulation and its implications for therapy.

Collaborations

Meller has collaborated with notable colleagues, including David A. Hildeman and Suhas G. Kallapur, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Jarek Meller's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapies targeting inflammation-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…